Location History:
- Brookline, MA (US) (2018)
- Cambridge, MA (US) (2020)
Company Filing History:
2 out of 2,893 
1 out of 2,968 
Years Active: 2018-2020
Title: Analise Z Reeves: Innovator in Engineered Microbial Cells
Introduction
Analise Z Reeves is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered microbial cells. With a total of 2 patents, her work focuses on innovative methods and compositions that enhance the capabilities of bacteria for therapeutic applications.
Latest Patents
Reeves' latest patents include groundbreaking technologies. One patent describes methods and compositions relating to engineered microbial cells. This invention details compositions and methods that involve engineered bacteria with a modified Type 3 Secretion System (T3SS). This modification allows the bacteria to deliver proteins to the extracellular space, which is a significant advancement over traditional methods that target the intracellular space of cells. Another patent focuses on compositions and methods for bacterial delivery of polypeptides. This technology utilizes engineered non-pathogenic bacteria that express a functional T3SS, enabling the delivery of a wide variety of polypeptides to target eukaryotic cells. The versatility of these methods opens up numerous applications in therapeutics and cellular reprogramming.
Career Highlights
Throughout her career, Analise Z Reeves has worked with esteemed organizations, including The General Hospital Corporation and Harvard College. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Reeves has collaborated with notable colleagues, including Cammie Lesser and Amy J Wagers. These partnerships have further enriched her research and innovation efforts.
Conclusion
Analise Z Reeves stands out as a key figure in the field of engineered microbial cells, with her patents paving the way for new therapeutic possibilities. Her work exemplifies the intersection of innovation and biotechnology, making a lasting impact on the industry.